FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to clinical laboratory diagnostics and cardiac surgery, and discloses a method for assessing myocardial damage and the risk of complications after heart surgery in conditions of extracorporeal circulation. The method is characterized by the fact that the level of highly sensitive troponin in the patient's blood is determined twice: after 2-6 hours - Tn early and after 12-24 hours - Tn late, the index of myocardial damage is calculated as the ratio of Tn late to Tn early and when the value of the damage index is 1, 8 or more assess myocardial damage and the risk of complications as high.
EFFECT: method allows assessing the degree of damage and the effectiveness of protection of the myocardium, as well as the risk of complications in the postoperative period and can be used in clinical practice.
1 cl, 3 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LABORATORY EVALUATION OF EXTRACORPORAL MEMBRANE OXYGENATION EFFECTIVENESS IN ADULT PATIENTS WITH ACUTE HEART FAILURE AFTER OPEN-HEART SURGERIES | 2016 |
|
RU2638808C1 |
METHOD FOR PREDICTION OF POSTOPERATIVE PERIOD IN ADULT PATIENTS WITH ACUTE HEART FAILURE AFTER OPEN HEART SURGERY THAT RECEIVE TREATMENT BY EXTRACORPORAL MEMBRANE OXYGENATION | 2016 |
|
RU2639096C1 |
METHOD FOR PREDICTING COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER CARDIAC SURGERIES WITH ARTIFICIAL CIRCULATION | 2017 |
|
RU2680602C1 |
METHOD FOR PREDICTION OF SEPSIS FOLLOWING CARDIOSURGICAL OPERATIONS PERFORMED IN CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION | 2019 |
|
RU2713930C1 |
ESTIMATION METHOD OF THE EFFICIENCY OF MEDICAL THERAPY IN ADULT PATIENTS WITH ACUTE HEART FAILURE AFTER OPERATIONS IN BARE HEART, RECEIVING TREATMENT WITH THE METHOD OF EXTRACORPORAL MEMBRANE OXYGENATION | 2016 |
|
RU2648529C1 |
METHOD FOR MYOCARDIAL PROTECTION ACCOMPANYING CARDIOPULMONARY BYPASS SURGERY FOR AORTIC VALVE REPLACEMENT | 2013 |
|
RU2538044C1 |
METHOD OF MYOCARDIUM PRECONDITIONING IN OPERATIONS UNDER CONDITIONS OF ARTIFICIAL BLOOD SUPPLY | 2012 |
|
RU2504336C1 |
METHOD OF PREDICTING ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITHIN A YEAR AFTER CORONARY ARTERY BYPASS GRAFTING | 2022 |
|
RU2801160C1 |
METHOD OF TREATING CARDIOVASCULAR PATIENTS AFTER SUFFERING ACUTE CORONARY SYNDROME AND CARDIOSURGICAL INTERVENTIONS | 2019 |
|
RU2715209C1 |
METHOD FOR IMMUNOLOGICAL PREDICTION OF SMALL MYOCARDIAL DAMAGE | 2014 |
|
RU2585391C1 |
Authors
Dates
2021-11-23—Published
2021-03-01—Filed